Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

7.00
0.0000
Post-market: 6.96-0.0400-0.57%19:59 EDT
Volume:2.60M
Turnover:18.15M
Market Cap:1.13B
PE:2.35
High:7.08
Open:7.07
Low:6.91
Close:7.00
Loading ...

Novavax’s Nuvaxovid Approval and Market Dynamics Justify Hold Rating Amid Unlocked Pipeline Potential

TIPRANKS
·
20 May

B. Riley says Novavax Nuvaxovid approval removes regulatory overhang

TIPRANKS
·
20 May

Novavax Stock (NVAX) Shoots 15% Higher as Covid Vaccine Jab Gets FDA Green Light

TIPRANKS
·
19 May

Novavax Boosts Vaccine Stocks; Gold Stocks and Long VIX ETFs Jump After US Downgrade

Tiger Newspress
·
19 May

Stock Track | Novavax Soars 29% as FDA Approves COVID-19 Vaccine, Triggering $175M Payment

Stock Track
·
19 May

Unusually active option classes on open May 19th

TIPRANKS
·
19 May

Novavax Shares up 26% After FDA Approves Co's Covid Vaccine With New Conditions

THOMSON REUTERS
·
19 May

U.S. Stocks Open Lower After US Downgrade; Novavax Surges 22% as FDA Approves Its COVID Vaccine

Tiger Newspress
·
19 May

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

Dow Jones
·
19 May

Morning Movers: Novavax jumps following FDA approval of Nuvaxovid BLA

TIPRANKS
·
19 May

Investor Sentiment Drops After Moody's Downgrade, Fueling Premarket Losses for US Equity Futures

MT Newswires Live
·
19 May

Update: Novavax Says COVID-19 Vaccine Approved by FDA; Shares Rise Pre-Bell

MT Newswires Live
·
19 May

Novavax’s COVID-19 Vaccine Gains FDA Approval

TIPRANKS
·
19 May

Pre-Bell|U.S. Futures Slide; Novavax Surges 17%; UnitedHealth Jumps 6%; Nvidia Drops 3%; Tesla Sinks 4%

Tiger Newspress
·
19 May

Top Premarket Gainers

MT Newswires Live
·
19 May

BUZZ-U.S. STOCKS ON THE MOVE-Novavax, gold miners, TXNM Energy

Reuters
·
19 May

Novavax Inc: for 2026 and 2027, We Expect to Reduce Our R&D and SG&a Expenses to About $350 Mln and About $250 Mln, Respectively

THOMSON REUTERS
·
19 May

Novavax Shares Rise on FDA License Application Approval for Nuvaxovid

Dow Jones
·
19 May

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Reuters
·
19 May

Novavax Announces FDA Approval for Nuvaxovid™ COVID-19 Vaccine, Triggers $175 Million Milestone Payment from Sanofi

Reuters
·
19 May